SHISA3 and breast cancer: Our results revealed that Aza treatment of both cell lines substantially enhanced SHISA3 mRNA levels (Fig 3A). On the other hand, SHISA3 promoter methylation level was significantly reduced in both BC cell lines after Aza treatment (Fig 3B).